Skip to content
PICO Portalanswers from OpenAlex

High rate of durable complete remission in follicular lymphoma after CD19 CAR-T cell immunotherapy

PaperCitations, authors & open-access status

High rate of durable complete remission in follicular lymphoma after CD19 CAR-T cell immunotherapy is a paper indexed in PICO Portal from OpenAlex.

How many citations does High rate of durable complete remission in follicular lymphoma after CD19 CAR-T cell immunotherapy have?

PICO Portalcitation count

High rate of durable complete remission in follicular lymphoma after CD19 CAR-T cell immunotherapy has 177 citations in the OpenAlex counts PICO Portal stores.

When was High rate of durable complete remission in follicular lymphoma after CD19 CAR-T cell immunotherapy published?

PICO Portalyear

High rate of durable complete remission in follicular lymphoma after CD19 CAR-T cell immunotherapy has 2019 year in the PICO Portal index.

What is the open-access status of High rate of durable complete remission in follicular lymphoma after CD19 CAR-T cell immunotherapy?

PICO Portaloa status

High rate of durable complete remission in follicular lymphoma after CD19 CAR-T cell immunotherapy has bronze oa status in the PICO Portal index.

What is the DOI of High rate of durable complete remission in follicular lymphoma after CD19 CAR-T cell immunotherapy?

PICO Portaldoi

The DOI for High rate of durable complete remission in follicular lymphoma after CD19 CAR-T cell immunotherapy is on the source record.

What is the PMID of High rate of durable complete remission in follicular lymphoma after CD19 CAR-T cell immunotherapy?

PICO Portalpmid

The PMID for High rate of durable complete remission in follicular lymphoma after CD19 CAR-T cell immunotherapy is on the source record.

What is the OpenAlex record for High rate of durable complete remission in follicular lymphoma after CD19 CAR-T cell immunotherapy?

PICO Portalopenalex

The OpenAlex for High rate of durable complete remission in follicular lymphoma after CD19 CAR-T cell immunotherapy is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial